The Rb/chromatin connection and epigenetic control: opinion
Abstract
The balance between cell differentiation and proliferation is regulated at the transcriptional level. In the cell cycle, the transition from G1 to S phase (G1/S transition) is of paramount importance in this regard. Indeed, it is only before this point that cells can be oriented toward the differentiation pathway: beyond, cells progress into the cycle in an autonomous manner. The G1/S transition is orchestrated by the transcription factor E2F. E2F controls the expression of a group of checkpoint genes whose products are required either for the G1-to-S transition itself or for DNA replication (e.g. DNA polymerase alpha). E2F activity is repressed in growth-arrested cells and in early G1, and is activated at mid-to-late G1. E2F is controlled by the retinoblastoma tumor suppressor protein Rb. Rb represses E2F mainly by recruiting chromatin remodeling factors (histone deacetylases and SWI/SNF complexes), the DNA methyltransferase DNMT1, and a histone methyltransferase. This review will focus on the molecular mechanisms of E2F repression by Rb during the cell cycle and during cell-cycle exit by differentiating cells. A model in which Rb irreversibly represses E2F-regulated genes in differentiated cells by an epigenetic mechanism linked to heterochromatin, and involving histone H3 and promoter DNA methylation, is discussed.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Loss of RB function may cause chromatin remodelling in differentiated cells, allowing cell cycle gene expression and de-differentiation.
“loss of RB function might result in chromatin remodelling in differentiated cells, allowing the expression of cell cycle genes and resulting in the de-differentiation of the mutant cells41,42.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [41]
The citation lists haven’t been fetched yet
References 74 · Cited by 76
- Authors
- Ferreira, R., Naguibneva, I., Pritchard, L. L., Ait-Si-Ali, S., & Harel-Bellan, A.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- ORCID
- Naguibneva, Irina
- Venue
- Oncogene
- Published
- 2001-05-28
- Volume
- 20
- Issue
- 24
- Pages
- 3128-3133
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2321351308
- Cited by
- 76
- References
- 74
- Citations by year
- 2024: 1 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 1 · 2017: 4 · 2016: 3 · 2015: 2 · 2014: 2 · 2013: 2 · 2012: 1
- FWCI
- 0.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Association pour la Recherche sur le Cancer
- Ligue Contre le Cancer
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- retinoblastoma protein, E2F transcription factors, G1/S transition, cell cycle regulation, cell differentiation, epigenetic regulation, chromatin remodeling, histone deacetylase, SWI/SNF complex, DNMT1, histone methyltransferase, heterochromatin, DNA methylation, histone H3, cell cycle exit, checkpoint genes
- MeSH terms
- Animals, Carrier Proteins, Cell Differentiation, Cell Division, Chromatin, DNA-Binding Proteins, Gene Expression Regulation, Humans, Transcription Factors, Retinoblastoma Protein, Cell Cycle Proteins, Transcription Factor DP1, E2F Transcription Factors, Retinoblastoma-Binding Protein 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review